Gene · 7003
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of YAP1 in liver cancer stem cells: proven and potential mechanisms. | Biomark Res | 2022 | 35672802 | PubTator, text mining | PubMed |
| Neoscytalidium novaehollandiae causes dieback on Pinus eldarica and its potential for infection of urban forest trees. | Sci Rep | 2022 | 35665773 | PubTator, text mining | PubMed |
| Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule. | Front Immunol | 2022 | 35655775 | PubTator, text mining | PubMed |
| YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis. | Nat Commun | 2022 | 35654829 | PubTator, text mining | PubMed |
| CircSLC8A1 Exacerbates Hypoxia-Induced Myocardial Injury via Interacting with MiR-214-5p to Upregulate TEAD1 Expression. | Int Heart J | 2022 | 35650159 | PubTator, text mining | PubMed |
| Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer. | Cancer Cell Int | 2022 | 35642057 | PubTator, text mining | PubMed |
| Mapping the cardiac vascular niche in heart failure. | Nat Commun | 2022 | 35641541 | PubTator, text mining | PubMed |
| USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ. | Int J Biol Sci | 2022 | 35637948 | PubTator, text mining | PubMed |
| Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. | J Pers Med | 2022 | 35629192 | PubTator, text mining | PubMed |
| Taxonomic and Phylogenetic Characterizations Reveal Four New Species, Two New Asexual Morph Reports, and Six New Country Records of Bambusicolous Roussoella from China. | J Fungi (Basel) | 2022 | 35628787 | PubTator, text mining | PubMed |
| Phase-Separated Subcellular Compartmentation and Related Human Diseases. | Int J Mol Sci | 2022 | 35628304 | PubTator, text mining | PubMed |
| Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. | Science | 2022 | 35617398 | PubTator, text mining | PubMed |
| Peptide 17 alleviates early hypertensive renal injury by regulating the Hippo/YAP signalling pathway. | Nephrology (Carlton) | 2022 | 35608936 | PubTator, text mining | PubMed |
| TEAD4 as an Oncogene and a Mitochondrial Modulator. | Front Cell Dev Biol | 2022 | 35602596 | PubTator, text mining | PubMed |
| Engineered Schwann Cell-Based Therapies for Injury Peripheral Nerve Reconstruction. | Front Cell Neurosci | 2022 | 35602558 | PubTator, text mining | PubMed |
| A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma. | Front Pharmacol | 2022 | 35600867 | PubTator, text mining | PubMed |
| Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection. | Front Oncol | 2022 | 35600397 | PubTator, text mining | PubMed |
| Bisphenol a exposure decreases learning ability through the suppression of mitochondrial oxidative phosphorylation in the hippocampus of male mice. | Food Chem Toxicol | 2022 | 35598803 | PubTator, text mining | PubMed |
| Single-nucleus chromatin accessibility profiling highlights regulatory mechanisms of coronary artery disease risk. | Nat Genet | 2022 | 35590109 | PubTator, text mining | PubMed |
| PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression. | Nat Commun | 2022 | 35589735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7003/papers?page=41